CYTOKINETICS INC
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Cytokinetics is a biopharmaceutical company focused on developing muscle biology-directed therapies for diseases affecting muscle function, including cardiac, skeletal, and smooth muscle disorders. Its pipeline includes drug candidates targeting cardiomyopathies and neuromuscular conditions such as ALS.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Blum Robert IPresident & CEO | Sell | $472K | 7,500at $62.88 | Oct 12, 2026 |
| Malik Fady IbrahamEVP Research & Development | Sell | $215K | 3,500at $61.38 | Oct 6, 2026 |
| Landry Robert EDirector | Sell | $75K | 1,000at $74.66 | Sep 11, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Gilbert CisnerosCA31 | House | Buy | $1,001 - $15,000 | Sep 29, 2026 |
| Gilbert CisnerosCA31 | House | Buy | $1,001 - $15,000 | Jun 30, 2026 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CYTK activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.